Quantcast
Channel: Latest Crohn's Disease News on BioPortfolio
Viewing all articles
Browse latest Browse all 2985

Coherus BioSciences Inc CHRS Financial and Strategic SWOT Analysis Review Report Updated 09032018 Prices from USD $300

$
0
0
SummaryCoherus BioSciences Inc Coherus BioSciences formerly known as BioGenerics Inc is a biosimilar platform company that develops and commercializes biosimilar drugs. The company's pipeline product candidates include CHS1701 an pegfilgrastim used to trea...

Viewing all articles
Browse latest Browse all 2985

Trending Articles